Truvestments Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$131K Sell
1,897
-30
-2% -$2.07K 0.03% 267
2025
Q1
$134K Sell
1,927
-169
-8% -$11.7K 0.03% 268
2024
Q4
$180K Buy
2,096
+113
+6% +$9.72K 0.05% 226
2024
Q3
$236K Buy
1,983
+29
+1% +$3.45K 0.06% 200
2024
Q2
$279K Hold
1,954
0.11% 170
2024
Q1
$251K Hold
1,954
0.1% 182
2023
Q4
$202K Hold
1,954
0.09% 208
2023
Q3
$178K Buy
1,954
+60
+3% +$5.46K 0.09% 190
2023
Q2
$153K Buy
1,894
+2
+0.1% +$162 0.08% 213
2023
Q1
$150K Buy
1,892
+90
+5% +$7.16K 0.08% 204
2022
Q4
$122K Hold
1,802
0.07% 211
2022
Q3
$90K Buy
1,802
+2
+0.1% +$100 0.06% 206
2022
Q2
$100K Buy
+1,800
New +$100K 0.06% 205
2022
Q1
Sell
-1,798
Closed -$101K 415
2021
Q4
$101K Hold
1,798
0.05% 209
2021
Q3
$86K Buy
1,798
+2
+0.1% +$96 0.05% 215
2021
Q2
$75K Buy
1,796
+4
+0.2% +$167 0.04% 220
2021
Q1
$60K Sell
1,792
-128
-7% -$4.29K 0.03% 264
2020
Q4
$67K Buy
+1,920
New +$67K 0.05% 223
2020
Q3
Sell
-1,918
Closed -$62K 469
2020
Q2
$62K Sell
1,918
-4,596
-71% -$149K 0.06% 187
2020
Q1
$196K Buy
+6,514
New +$196K 0.25% 90
2019
Q4
Sell
-5,264
Closed -$136K 435
2019
Q3
$136K Hold
5,264
0.09% 158
2019
Q2
$134K Buy
5,264
+4,756
+936% +$121K 0.09% 161
2019
Q1
$13K Buy
+508
New +$13K 0.01% 479
2018
Q3
$12K Buy
+508
New +$12K 0.01% 604